Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959

This article has now been updated. Please use the final version.

Successful diagnosis and treatment of pheochromocytoma during severe coronavirus disease 2019 (COVID-19): a case report
Yasutaka Tsujimoto, Masaaki Yamamoto, Seiji Nishikage, Keitaro Kanie, Maki Kanzawa, Hironori Bando, Kei Yoshino, Yushi Hirota, Hidenori Fukuoka, Wataru Ogawa
Author information
JOURNAL FREE ACCESS Advance online publication

Article ID: EJ22-0446

Details
Abstract

Pheochromocytoma is a rare but life-threatening condition due to catecholamine release induced by drug treatments such as β-blockers or glucocorticoids. We present a case of hypertensive crisis due to pheochromocytoma, induced after the initiation of dexamethasone and landiolol during intensive care for severe coronavirus disease 2019 (COVID-19). Based on a detailed medical history review, the patient was previously diagnosed with primary aldosteronism by confirmatory tests, moreover, an abdominal computed tomography scan identified an adrenal tumor 2 years before current admission. We tentatively diagnosed the patient with pheochromocytoma and initiated α-blockers without conducting a catecholamine report, leading to stable hemodynamics. We present a successfully managed case of pheochromocytoma concomitant with COVID-19, which has become a global crisis.

Content from these authors
© The Japan Endocrine Society
feedback
Top